Unfortunately, we don't support Internet Explorer anymore as it has been replaced by Microsoft Edge. Please try using Edge or an alternative modern browser for the best experience.
Mr. Sekhri has over 35 years of experience in the Life Science Industry. His experience encompasses senior management in large corporate pharmaceutical and biotechnology companies, as well as private equity and venture capital.
Mr. Sekhri is President and Chief Executive Officer of vTv Therapeutics, Inc. Most recently he served as President and CEO of eGenesis, Inc. from 2019-2022, where he was a Board Member and Senior Advisor to the Chairman until 2024. Prior to joining eGenesis, he was President and CEO of Lycera Corp. from 2015-2019. Prior to this, he served as Senior Vice President, Integrated Care for Sanofi from 2014-2015. Previously, he served as Chief Strategy Officer and Group Executive Vice President, Global Business Development for Teva Pharmaceutical Industries, Ltd.
Prior to joining Teva, he spent five years as Operating Partner and Head of the Biotechnology Operating Group at TPG Biotech, the life sciences venture capital arm of TPG Capital. From 2004-2009, Mr. Sekhri was Founder, President, and Chief Executive Officer of Cerimon Pharmaceuticals, Inc. Prior to founding Cerimon, Mr. Sekhri was President and Chief Business Officer of ARIAD Pharmaceuticals, Inc. Previously, Mr. Sekhri spent five years at Novartis as Senior Vice President, and Head of Global Search and Evaluation, Business Development and Licensing for Novartis Pharma AG.
Mr. Sekhri has been a Director on more than 35 private, public company, and nonprofit Boards and is currently a member of the Board of Directors of Veeva Systems, Chair of the Board at Compugen Ltd., and Kaerus Bioscience. He is also on the Board of AdhereTech Inc. He was, until recently, the Chairman of the Board of Pharming N.V. and was also Chair of the Board of Longboard, Inc. until its recent sale to Lundbeck. He also spent five years on the Board of Ipsen, S.A. Additionally, he is on the Board of Directors of The Metropolitan Opera and was a member of the Board of Trustees of Carnegie Hall. Most recently, he was nominated as Chairman of the Board of Trustees of Young Concert Artists, Inc.
